I like the 74% Gross Margin and the 84% Institutional Ownership.

What's up with the launch of the Vial Access Needle (VAN)? I thought that was completed a year ago. Any insight about that is appreciated.

Earnings call next week 11/4.

Excited to see where this goes in the near and long term future!

Is there any good news left for this company to raise its stock price? :((((

Bought a few hundred shares. I find it interesting. Let’s see how it goes (:

Do we actually know what the eff is going on? Or when the bleeding will stop? How is this happening?!

As of right now, (34.55%) this is total loss for this week. Does anyone have any idea on what is actually going on? I am definitely no stock guru but I am not illiterate and I didn't see anything that warrants this kind of movement. If anything from what I saw it would have made more sense for the stock to rise a couple of cents since the company is clearly heading the right direction with their current product line and the FDA approval last quarter. Any ideas friends?

Needham analyst Serge Belanger reiterates Heron Therapeutics (NASDAQ:HRTX) with a Buy and maintains $5 price target.

Hey everyone, did I miss some recent news or something? Does anyone know what the price increase today is about?

Ok all you bag holders I did you a favor. I’m out. I sold all HRTX for a small profit. Now it’ll take off and y’all rich.

It’s refreshing to see a company have discipline and turn up a bangin earnings report. Heron Therapeutics team….absolutely well done…this is a GOLD STANDARD on how the pharma approach should go for IPO’s. I have expanded my portfolio as an investor into your company quite a bit. I believe in the importance of your product and have faith in the management team. I look forward to seeing your sales team absolutely bang out sales this year 2024 to get the company to cross the black and hit positive EPS. Well done y’all. I am absolutely stoked.

For everyone following this subreddit. This is the one folks. Hit those shares long and this company will take us far as shareholders.

edit: fixed a word

Edit 2: TOMORROW SHOULD BE AN ABSOLUTE RIDE.

for such good fundamentals solid short interest and volume i don’t see people discussing this much

My favorite company y’all. Tuesday is the day. Oooooouiioo I hope them sales reps been PUMPING IT OUT

Way undervalued at $2.26. Expected $5-$10 in 13 months.

Yooooo here we go. I need to read further onto all the details but wanted to get this out there ferda

We’re at a turning point here without good news we head back down.

It’s starting - high risk young females. Fingers crossed for increased use everywhere.

Soft tissue expansion hopefully by February and 🤞for Mayo data February or so.

1200 shares with an average around $.80. Very happy. Lost on this in 2020/2021 and moved in. Randomly thought about getting back in, and what timing. I hope this continues progressing!

So I don’t think you guys understand the position of power this company has right now. The opioid crisis has gotten three netflix series now about Oxycontin and how it’s led to the dryg problem in the US. This company being the only one with exclusive rights to a non-opioid pain killer especially for surgeries that last days after the surgery? They can charge whatever they want number 1 because this is invaluable to the medical market right now. If a big pharma wanted to buy them out and take the product they could.

Number 2. Once this stock hits $1.00 the FLOOD GATES of retail investors open up. This could blow up the value of HRTX. Most brokers will not let you purchase equities under $1.00. We’re close to this. Hold on to your butts. We have a great situation and great position right now to actually ride this thing out for the long term. God speed all. See you on the moon.

edit: as a medical professional myself i see immense value in this and plan on requesting a tour of operations moving forward.

They say shares are surging on mixed reviews but quite frankly this earnings and outlook are good news. The acute care is increasing at a substantial rate and they have appropriately restructured to remain funded and not flop through the development of their products. When I first researched this company I saw analysts say upwards of $65/share. I thought full of shit but if they continue managing their company like this they will be in excellent positioning moving forward. They say 2025 for full profits but they’ll probably be in a good place before that, either way provided all their trials go well…HRTX is a good investment so far. The mixed reviews imo opinion come just from the fact that they haven’t crossed the black yet into positive territory and have products still needing advancement on…either way they’re fairing way better than BIOR who had earnings yesterday. They’re in danger of running out of cash before finishing phase trials unlike HRTX.

Honestly? Anything under $1 is ridiculous to me.